Your browser doesn't support javascript.
loading
α-Hederin inhibits the platelet activating factor-induced metastasis of HCC cells through disruption of PAF/PTAFR axis cascaded STAT3/MMP-2 expression.
Cao, Linna; Zhang, Yiwei; Mi, Jinxia; Shi, Zhanhao; Fang, Zhaoqin; Jia, Dongwei; Pan, Zhiqiang; Peng, Peike.
Afiliación
  • Cao L; School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Zhang Y; Department of Anesthesiology, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, China.
  • Mi J; Science and Technology Center, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Shi Z; School of Pharmacy, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Fang Z; School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
  • Jia D; School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: jiadongwei@fudan.edu.cn.
  • Pan Z; School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: pzq527@163.com.
  • Peng P; School of Basic Medical Sciences, Shanghai University of Traditional Chinese Medicine, Shanghai, China. Electronic address: pengpeike@shutcm.edu.cn.
Pharmacol Res ; 178: 106180, 2022 04.
Article en En | MEDLINE | ID: mdl-35288308

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ácido Oleanólico / Saponinas / Factor de Activación Plaquetaria / Carcinoma Hepatocelular / Metaloproteinasa 2 de la Matriz / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmacol Res Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Ácido Oleanólico / Saponinas / Factor de Activación Plaquetaria / Carcinoma Hepatocelular / Metaloproteinasa 2 de la Matriz / Neoplasias Hepáticas Tipo de estudio: Prognostic_studies Idioma: En Revista: Pharmacol Res Año: 2022 Tipo del documento: Article País de afiliación: China